<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02639793</url>
  </required_header>
  <id_info>
    <org_study_id>AFOulu</org_study_id>
    <nct_id>NCT02639793</nct_id>
  </id_info>
  <brief_title>Effects of Catheter Ablation on Burden of Atrial Fibrillation (MRICEMAN)</brief_title>
  <acronym>MRICEMAN</acronym>
  <official_title>A Nationwide Multicenter Trial Assessing the Effects of Catheter Ablation on Burden of Atrial Fibrillation Recorded by Implantable Cardiac Monitor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heikki Huikuri</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will assess the atrial fibrillation burden recorded By implantable loop recorder at
      12 and 24 months compared to baseline. The patients with clinical indication fo catheter
      ablation of paroxysmal atrial fibrillation will be randomized to three techniques: manual
      radiofrequency ablation, radiofrequency ablation using remote magnet monitoring, and
      cryoablation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 300 patients will be randomized to three different catheter ablation techniques
      (100 patients/group); radiofrequency ablation using remote magnet navigation, radiofrequency
      ablation using manual method, and cryoablation. A loop recorder (REVEAL) is implanted one
      month before the catheter ablation of paroxysmal atrial fibrillation and the effects of
      atrial fibrillation burden will be compared between the three methods at 12 and 24 months
      after ablation excluding the first three monthsÂ´ blanking period.

      The primary endpoints are:

        1. the proportion of patients remaining free from atrial fibrillation, atrial flutter or
           atrial tachycardia (&gt; 2 minutes) recorded by the implantable cardiac monitor (Medtronic)
           at 24 months follow-up and

        2. total atrial fibrillation burden recorded by the loop recorder.

      Other endpoints:

        1. Atrial fibrillation burden in 7 days Holter recording at 12 and 24 months compared to
           baseline,

        2. the time to first documented symptomatic and asymptomatic recurrence of atrial
           fibrillation

        3. prescription of antiarrhythmic drugs after the 3 months blanking period following the
           ablation

        4. re-ablation after the index ablation procedure,

        5. total procedural duration;

        6. total time of fluoroscopy and radiation dose;

        7. number and duration of cardiovascular hospitalization;

        8. quality of life questionnaires at 12 months and 24 month compared with baseline,

        9. cognitive function at 12 and 24 month compared with baseline,

       10. cost-efficacy of the different ablation techniques.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">January 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Free of atrial fibrillation</measure>
    <time_frame>24 months</time_frame>
    <description>the proportion of patients remaining free from AF, atrial flutter (AFL) or atrial tachycardia (AT) (&gt; 2 minutes) recorded by the implantable cardiac monitor (ICM, Reveal, Medtronic Co.) at 24 months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total AF burden</measure>
    <time_frame>24 months</time_frame>
    <description>total AF burden recorded by the implantable loop recorder during the 24 month follow-up.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>24 months</time_frame>
    <description>Safety is one of the secondary endpoints. The following potential adverse events will be monitored: Any previous left atrial ablation or surgery Any cardiac surgery or percutaneous coronary intervention within three months prior to enrolment.
Secondary AF Stroke or transient ischemic attack within six months prior to enrolment Myocardial infarction within three months prior to enrolment Left ventricular ejection fraction &lt; 40 % Anteroposterior left atrial diameter &gt;55 mm by transthoracic or transesophageal echocardiography Implanted prosthetic valve</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>manual radiofrequency ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiofrequency catheter ablation using manual catheter manipulation will be used as an ablation technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>magnet navigation ablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiofrequency catheter ablation using remote magnet navigation will be used as an ablation technique.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cryoablation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Catheter ablation using cryoablation technique will be used as an ablation technique of atrial fibrillation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>catheter ablation</intervention_name>
    <description>Three different catheter ablation techniques will be used aimed at isolating the pulmonary veins from left atrium.The endpoint is defined as absence or dissociation of all pulmonary vein potentials as confirmed by the circular mapping catheter after a waiting period of 30 minutes after the last ablation. The use of adenosine or isoproterenol to detect concealed pulmonary vein conduction is voluntary.</description>
    <arm_group_label>manual radiofrequency ablation</arm_group_label>
    <arm_group_label>magnet navigation ablation</arm_group_label>
    <arm_group_label>cryoablation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Patients with symptomatic paroxysmal atrial fibrillation fulfilling the contemporary
             guideline criteria for AF ablation

        Exclusion Criteria:

        - Any contraindication to catheter ablation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Heikki Huikuri, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oulu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Heikki Huikuri, Prof</last_name>
    <phone>+358400892330</phone>
    <email>heikki.huikuri@oulu.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Pekka Raatikainen, Prof</last_name>
    <phone>+35883154108</phone>
    <email>pekka-raatikainen@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>UOulu</name>
      <address>
        <city>Oulu</city>
        <zip>90014</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heikki Huikuri, Prof</last_name>
      <phone>+35883155599</phone>
      <email>heikki.huikuri@oulu.fi</email>
    </contact>
    <contact_backup>
      <last_name>Pekka Raatikainen, prof</last_name>
      <phone>+3588400892330</phone>
      <email>pekka.raatikainen@hus.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Heikki Huikuri</name>
      <address>
        <city>Oulu</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Heikki Huikuri, Prof</last_name>
      <phone>+35883154108</phone>
      <email>heikki.huikuri@oiulu.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <link>
    <url>http://www.oulu.fi/yliopisto</url>
    <description>wep-page</description>
  </link>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2015</study_first_submitted>
  <study_first_submitted_qc>December 22, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2015</study_first_posted>
  <last_update_submitted>December 24, 2015</last_update_submitted>
  <last_update_submitted_qc>December 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Oulu</investigator_affiliation>
    <investigator_full_name>Heikki Huikuri</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>arrhythmias, quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

